nordidemnin b has been researched along with arginine vasopressin in 1 studies
| Studies (nordidemnin b) | Trials (nordidemnin b) | Recent Studies (post-2010) (nordidemnin b) | Studies (arginine vasopressin) | Trials (arginine vasopressin) | Recent Studies (post-2010) (arginine vasopressin) |
|---|---|---|---|---|---|
| 6 | 0 | 0 | 12,278 | 422 | 1,212 |
| Protein | Taxonomy | nordidemnin b (IC50) | arginine vasopressin (IC50) |
|---|---|---|---|
| Vasopressin V2 receptor | Homo sapiens (human) | 0.242 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dominice, C; Dufour, MN; Grazzini, E; Guillon, G; Jouin, P; Manzoni, O; Patino, N | 1 |
1 other study(ies) available for nordidemnin b and arginine vasopressin
| Article | Year |
|---|---|
Dual effects of nordidemnin on WRK1 cells: inhibition of phosphoinositide metabolism and cell proliferation.
Topics: Animals; Antibiotics, Antineoplastic; Arginine Vasopressin; Calcium; Cell Division; Cyclosporine; Depsipeptides; Female; Inositol; Peptides, Cyclic; Phosphatidylinositols; Rats; Tumor Cells, Cultured; Type C Phospholipases | 1994 |